ONWARDS 5 is a global programme of clinical studies to investigate how well a new investigational insulin taken once weekly, insulin icodec, controls blood sugar in people with diabetes.
Once-weekly insulin icodec will be compared with insulins taken daily, which are already available on the market.
As part of the programme, this study is comparing the effectiveness and safety of once-weekly insulin icodec with that of daily insulin over a period of 14 months.